Market Tracker

08/23 5:16pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

51.98
Delayed Data
As of Aug 23
 -0.68 / -1.29%
Today’s Change
37.35
Today|||52-Week Range
55.38
+34.32%
Year-to-Date

Today’s Trading

Previous close52.66
Today’s open52.34
Day’s range51.62 - 52.45
Volume739,273
Average volume (3 months)1,110,729
Market cap$4.6B
Dividend yield--
Data as of 4:00pm ET, 08/23/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-48.47%
Earnings growth (next 5 years)-13.59%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book14.53

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp-0.13-0.32%
TECHBio-Techne Corp-0.36-0.30%
BLUEbluebird bio Inc+0.40+0.42%
BIVVBioverativ Inc-1.12-1.99%
Data as of 4:00pm ET, 08/23/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
President, Chief Operating &
Financial Officer
David-Alexandre C. Gros
Corporate headquarters
San Diego, California

Forecasts